Free tool
FAERS Monitor: Pulmicort Respules
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020929 or its brand name (Pulmicort Respules, Budesonide). Reports on generic versions are filed under their own applications.
Reports
42,547
Serious
32,411
76% of reports
Hospitalization
15,678
Death reported
3,177
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective4,994
- dyspnoea4,876
- off label use4,639
- asthma3,791
- fatigue2,641
- condition aggravated2,522
- headache2,477
- diarrhoea2,412
- cough2,387
- pneumonia2,319
- nausea2,151
- wheezing2,124
- pyrexia1,942
- pain1,893
- weight decreased1,753
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 161 |
| 2005 | 230 |
| 2006 | 219 |
| 2007 | 434 |
| 2008 | 576 |
| 2009 | 570 |
| 2010 | 549 |
| 2011 | 563 |
| 2012 | 822 |
| 2013 | 840 |
| 2014 | 1,041 |
| 2015 | 1,402 |
| 2016 | 1,632 |
| 2017 | 1,742 |
| 2018 | 2,306 |
| 2019 | 3,015 |
| 2020 | 3,624 |
| 2021 | 3,765 |
| 2022 | 4,013 |
| 2023 | 3,995 |
| 2024 | 4,143 |
| 2025 | 4,049 |
| 2026 | 2,856 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,011,612 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| wheezingSignal | 2,124 | 18.3 | 17.6 | 33,625 |
| asthmaSignal | 3,791 | 17.1 | 16.6 | 55,908 |
| dyspnoeaSignal | 4,876 | 4.3 | 4.2 | 12,513 |
| coughSignal | 2,387 | 4.2 | 4.1 | 5,925 |
| condition aggravatedSignal | 2,522 | 4.1 | 4.0 | 6,009 |
| pneumoniaSignal | 2,319 | 3.6 | 3.4 | 4,300 |
| weight decreasedSignal | 1,753 | 3.1 | 3.0 | 2,537 |
| pyrexiaSignal | 1,942 | 2.8 | 2.7 | 2,244 |
| off label useSignal | 4,639 | 2.6 | 2.6 | 4,853 |
| headache | 2,477 | 2.0 | 1.9 | 1,189 |
| drug ineffective | 4,994 | 1.9 | 1.8 | 2,172 |
| diarrhoea | 2,412 | 1.9 | 1.8 | 968 |
| fatigue | 2,641 | 1.7 | 1.6 | 750 |
| pain | 1,893 | 1.5 | 1.5 | 351 |
| nausea | 2,151 | 1.3 | 1.3 | 196 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.